Merck Serono S.A.
1211 Geneva, 20, Switzerland (Map) Phone: +41-22-414-3000
Fax: +41-22-414-2179
http://www.merckserono.com
Overview
The fertile minds at Merck Serono help people around the world combat infertility. One of the world's top biotechs, Merck Serono focuses on recombinant genetic engineering to develop drugs. The firm manufactures and markets therapies for neurological, metabolic, endocrinology, oncology, cardiovascular, and growth disorders, among others. It is a leader in reproductive health; flagship drug Gonal-F is a leading infertility product line. Other key products include beta interferon drug Rebif for the treatment of multiple sclerosis (MS) and colorectal and head/neck cancer treatment Erbitux. The company is German drugmaker Merck KGaA's largest subsidiary, responsible for its pharmaceutical research.
Sample Overview & HistoryKey Numbers from Hoover's UK
Key financials for Merck Serono S.A.
| Company Type | Subsidiary of Merck KGaA |
|---|---|
| Fiscal Year-End | December |
Key People from Hoover's UK
Key people and executives for Merck Serono S.A.
| President | Stefan Oschmann (Subscribers see complete biographies -- view sample)
|
|---|---|
| COO | Belén Garijo |
| SVP Divisional Controlling | Dorothea Wenzel |
Top Competitors from Hoover's UK
Top competitors of Merck Serono S.A.
There are 17 competitors for Merck Serono; see more.Industry Information from Hoover's UK
First Research Industry Profiles Extensive Industry Intelligence
Hoover's Industries
More Industry InformationSubsidiaries/Affiliates Covered By Hoover's UK
Subsidiaries/affiliates of Merck Serono S.A.
